- Home
- GH vs LTH Comparison
GH vs LTH Comparison
Compare GH & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- LTH
- Stock Information
- Founded
- GH 2011
- LTH 1992
- Country
- GH United States
- LTH United States
- Employees
- GH N/A
- LTH N/A
- Industry
- GH Medical Specialities
- LTH Hotels/Resorts
- Sector
- GH Health Care
- LTH Consumer Discretionary
- Exchange
- GH Nasdaq
- LTH Nasdaq
- Market Cap
- GH 4.9B
- LTH 5.5B
- IPO Year
- GH 2018
- LTH 2021
- Fundamental
- Price
- GH $65.46
- LTH $25.68
- Analyst Decision
- GH Strong Buy
- LTH Buy
- Analyst Count
- GH 22
- LTH 12
- Target Price
- GH $64.91
- LTH $36.54
- AVG Volume (30 Days)
- GH 2.2M
- LTH 2.0M
- Earning Date
- GH 10-29-2025
- LTH 11-04-2025
- Dividend Yield
- GH N/A
- LTH N/A
- EPS Growth
- GH N/A
- LTH 93.31
- EPS
- GH N/A
- LTH 1.03
- Revenue
- GH $828,849,000.00
- LTH $2,824,027,000.00
- Revenue This Year
- GH $28.30
- LTH $14.65
- Revenue Next Year
- GH $22.98
- LTH $11.15
- P/E Ratio
- GH N/A
- LTH $25.06
- Revenue Growth
- GH 28.74
- LTH 17.25
- 52 Week Low
- GH $20.14
- LTH $21.49
- 52 Week High
- GH $68.23
- LTH $34.99
- Technical
- Relative Strength Index (RSI)
- GH 59.00
- LTH 39.07
- Support Level
- GH $61.00
- LTH $24.76
- Resistance Level
- GH $68.22
- LTH $25.97
- Average True Range (ATR)
- GH 2.50
- LTH 0.69
- MACD
- GH 0.12
- LTH -0.13
- Stochastic Oscillator
- GH 64.47
- LTH 26.68
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.